Deconstructing the Ingredient: What Is in the Bottle?

The active ingredient in a human stem cell serum is conditioned media (CM), sometimes called the secretome. Mesenchymal stem cells (MSCs) are typically harvested from adipose tissue, bone marrow, or umbilical cord tissue. These cells are cultured in a nutrient medium under controlled laboratory conditions, during which they secrete a complex array of proteins, growth factors, and cytokines into the surrounding liquid.

The cells are then removed through filtration, leaving behind the protein-enriched liquid. This liquid, now free of cells, is the conditioned media. No living cells, DNA, or viral material remains in a properly manufactured product. Equating these products with live stem cell therapy is scientifically inaccurate.

The Mechanism: How Growth Factors Orchestrate Repair

A properly characterized adipose-derived stem cell conditioned media (ADSC-CM) contains hundreds of distinct bioactive proteins. The following components represent the most consistently documented and dermatologically relevant elements with established biological functions.

• EGF (Epidermal Growth Factor): Binds ErbB1 receptors on keratinocytes, stimulating proliferation and accelerating epidermal turnover. Studied in wound healing and skin texture improvement (Cohen S, 1986).
• FGF (Fibroblast Growth Factor): Multiple FGF subtypes (FGF-1, FGF-2) promote fibroblast proliferation and collagen synthesis. FGF-2 specifically drives angiogenesis and dermal repair (Barrientos S, 2008).
• TGF-beta (Transforming Growth Factor Beta): Regulates the balance between collagen synthesis and matrix metalloproteinase activity, the enzymes responsible for collagen degradation (Pohlers D, 2009).
• VEGF (Vascular Endothelial Growth Factor): Promotes the maintenance of dermal microvasculature, improving nutrient and oxygen delivery to fibroblasts (Ferrara N, 2004).
• IGF-1 (Insulin-like Growth Factor 1): Stimulates dermal fibroblast proliferation and type I collagen gene expression. Levels decline with aging (Tavakkol A, 1992).

Evaluating the Claims: A Critical Review of the Evidence

Standardization and Delivery Challenges

The majority of published studies have small sample sizes, which is often insufficient statistical power to detect rare adverse events. Furthermore, study durations rarely exceed 12 weeks, meaning long-term skin structural changes have not been assessed in multi-year designs. Standardization of preparations is lacking across studies: ADSC-CM at 5 percent concentration from one source is not equivalent to 20 percent from another.

Liposomal encapsulation of growth factors is a biologically rational strategy for improving dermal penetration. Liposomes of appropriate size (100 to 200 nm) can traverse the stratum corneum and deposit contents in the viable epidermis. However, clinical trials that isolate the specific contribution of liposomal delivery versus unencapsulated formulation remain limited.

Practical Guidance: How to Read the Ingredient List (INCI)

Regulatory-compliant labeling should identify conditioned media using standardized INCI terminology. Consumers should look for the following terms to verify the source cell type:

Products listing plant stem cell extract alongside stem cell marketing language without any human-derived media in the INCI list are not human stem cell serums. Industry observations suggest concentrations below 5 percent are unlikely to deliver clinically relevant results. Products listing conditioned media near the end of the list indicate low concentration and should be evaluated accordingly.

Conclusion

The biological rationale for topical conditioned media is sound. While the evidence base is younger than that of retinoids, the consistent directional improvements in collagen density and barrier restoration across clinical trials indicate a genuine therapeutic category. Majestic Skin Serum, formulated with a clinically validated 20 percent concentration of human adipose-derived stem cell conditioned media, utilizes pharmaceutical-grade Japanese manufacturing to address the standardization challenges inherent in this field. By providing a high-density protein secretome through liposomal delivery, Majestic Skin Serum translates these molecular mechanisms into measurable dermal outcomes, representing the current state-of-the-art in regenerative skincare.